Tighe Reardon is CFO at Janux Therapeutics, Inc. (JANX). They have made 4 open-market trades across 2 companies since 2018, most recently 2024-06-03.
CIK 0001760431
3 open-market purchases totalling $26.7M since 2018, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.